https://apmonia-therapeutics.com/index.php/2020/09/22/apmonia-therapeutics-06/ 2020-09-29T08:33:53+00:00 http://apmonia-therapeutics.com/wp-content/uploads/2020/08/bama_large-768x365-1.jpg https://apmonia-therapeutics.com/index.php/2020/07/28/apmonia-therapeutics-04/ 2020-10-21T14:19:30+00:00 http://apmonia-therapeutics.com/wp-content/uploads/2020/08/0.jpg https://apmonia-therapeutics.com/index.php/2020/07/02/apmonia-therapeutics-03/ 2020-10-21T14:19:39+00:00 http://apmonia-therapeutics.com/wp-content/uploads/2020/07/AdobeStock_31749306_2-scaled.jpg https://apmonia-therapeutics.com/index.php/2019/12/18/apmonia-therapeutics-01/ 2020-10-21T14:19:43+00:00 http://apmonia-therapeutics.com/wp-content/uploads/2020/08/apmonia-news01.jpg https://apmonia-therapeutics.com/index.php/2019/09/25/apmonia-therapeutics-02/ 2020-12-01T16:54:14+00:00 http://apmonia-therapeutics.com/wp-content/uploads/2020/08/AdobeStock_3302930072-scaled.jpg https://apmonia-therapeutics.com/index.php/2020/07/28/apmonia-therapeutics-05/ 2020-12-01T17:34:35+00:00 http://apmonia-therapeutics.com/wp-content/uploads/2020/12/Press-release-July-30-2020_Page_1-scaled.jpg http://apmonia-therapeutics.com/wp-content/uploads/2020/12/Press-release-July-30-2020_Page_1-scaled.jpg http://apmonia-therapeutics.com/wp-content/uploads/2020/12/Press-release-July-30-2020_Page_2.jpg https://apmonia-therapeutics.com/index.php/2020/12/01/new-scientific-publication/ 2020-12-02T11:10:44+00:00 http://apmonia-therapeutics.com/wp-content/uploads/2020/12/Unknown.png https://apmonia-therapeutics.com/index.php/2021/10/14/new-scientific-publication-2/ 2021-10-14T10:56:55+00:00 http://apmonia-therapeutics.com/wp-content/uploads/2021/10/Capture-d%E2%80%99%C3%A9cran-2021-10-14-%C3%A0-12.53.34.png https://apmonia-therapeutics.com/index.php/2022/02/10/apmonia-therapeutics-announces-a-4-me-fundraising-round/ 2022-02-10T09:01:38+00:00 http://apmonia-therapeutics.com/wp-content/uploads/2022/02/ApmoniaTx_PressRelease_20220210_Page_1.jpg http://apmonia-therapeutics.com/wp-content/uploads/2022/02/ApmoniaTx_PressRelease_20220210_Page_1.jpg http://apmonia-therapeutics.com/wp-content/uploads/2022/02/ApmoniaTx_PressRelease_20220210_Page_2.jpg http://apmonia-therapeutics.com/wp-content/uploads/2022/02/ApmoniaTx_PressRelease_20220210_Page_3.jpg https://apmonia-therapeutics.com/index.php/2022/02/10/apmonia-therapeutics-annonce-une-nouvelle-levee-de-fonds-de-4-me/ 2022-02-10T09:01:52+00:00 http://apmonia-therapeutics.com/wp-content/uploads/2022/02/ApmoniaTx_CommuniquePresse_20220210_Page_1.jpg http://apmonia-therapeutics.com/wp-content/uploads/2022/02/ApmoniaTx_CommuniquePresse_20220210_Page_1.jpg http://apmonia-therapeutics.com/wp-content/uploads/2022/02/ApmoniaTx_CommuniquePresse_20220210_Page_2.jpg http://apmonia-therapeutics.com/wp-content/uploads/2022/02/ApmoniaTx_CommuniquePresse_20220210_Page_3.jpg https://apmonia-therapeutics.com/index.php/2022/09/02/apmonia-therapeutics-announces-a-e2-5-million-financing-to-develop-its-lead-candidate-targeting-solid-cancers/ 2022-09-02T07:25:48+00:00 http://apmonia-therapeutics.com/wp-content/uploads/2022/09/ApmoniaTx_PR_Funding202208_US-1-1.png http://apmonia-therapeutics.com/wp-content/uploads/2022/09/ApmoniaTx_PR_Funding202208_US-1.png http://apmonia-therapeutics.com/wp-content/uploads/2022/09/ApmoniaTx_PR_Funding202208_US-2.png https://apmonia-therapeutics.com/index.php/2022/12/05/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency/ 2022-12-05T15:42:53+00:00 http://apmonia-therapeutics.com/wp-content/uploads/2022/12/2022-12-05_16h26_23.png http://apmonia-therapeutics.com/wp-content/uploads/2022/12/2022-12-05_16h26_23.png http://apmonia-therapeutics.com/wp-content/uploads/2022/12/2022-12-05_16h26_36-1.png https://apmonia-therapeutics.com/index.php/2023/07/11/apmonia-therapeutics-appoints-professor-liliana-schaefer-to-scientific-and-clinical-advisory-board/ 2023-07-11T09:00:20+00:00 http://apmonia-therapeutics.com/wp-content/uploads/2023/07/Bildschirmfoto-2023-04-12-um-20.04.16.png http://apmonia-therapeutics.com/wp-content/uploads/2023/07/1.png http://apmonia-therapeutics.com/wp-content/uploads/2023/07/2.png https://apmonia-therapeutics.com/index.php/2023/09/12/apmonia-therapeutics-announces-a-new-licensing-agreement-with-satt-nord-to-strengthen-its-portfolio-of-innovative-peptides-for-oncology/ 2023-09-12T07:39:37+00:00 http://apmonia-therapeutics.com/wp-content/uploads/2023/09/2023-09-12_09h39_10.png http://apmonia-therapeutics.com/wp-content/uploads/2023/09/2023-09-12_09h18_39.png http://apmonia-therapeutics.com/wp-content/uploads/2023/09/2023-09-12_09h19_06.png https://apmonia-therapeutics.com/index.php/2024/04/23/apmonia-tx-announces-a-e2-7m-financing-to-develop-its-clinical-candidate-and-strengthen-its-discovery-platform/ 2024-04-23T09:15:56+00:00 http://apmonia-therapeutics.com/wp-content/uploads/2024/04/2023-09-12_09h39_10.png https://apmonia-therapeutics.com/index.php/2024/07/16/apmonia-therapeutics-to-receive-e2-5m-grant-and-e7m-equity-investment-from-the-european-innovation-council-eic-as-a-laureate-of-the-eic-accelerator-program/ 2024-07-16T15:17:23+00:00 http://apmonia-therapeutics.com/wp-content/uploads/2024/07/visuel-CP.png https://apmonia-therapeutics.com/index.php/2024/12/16/apmonia-therapeutics-strengthens-its-drug-discovery-capabilities-and-extends-its-collaboration-with-the-max-mousseron-institute-of-biomolecules-ibmm/ 2024-12-16T15:29:02+00:00 http://apmonia-therapeutics.com/wp-content/uploads/2019/04/photo_1-1.jpg https://apmonia-therapeutics.com/index.php/2026/02/03/apmonia-therapeutics-secures-e10-million-to-advance-first-in-human-development-of-first-in-class-cancer-therapy-tax2/ 2026-02-03T08:17:52+00:00 http://apmonia-therapeutics.com/wp-content/uploads/2019/04/photo_1-1.jpg